Your browser doesn't support javascript.
loading
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.
Chen, Xian; Low, Kwang-Huei; Alexander, Angela; Jiang, Yufeng; Karakas, Cansu; Hess, Kenneth R; Carey, Jason P W; Bui, Tuyen N; Vijayaraghavan, Smruthi; Evans, Kurt W; Yi, Min; Ellis, D Christian; Cheung, Kwok-Leung; Ellis, Ian O; Fu, Siqing; Meric-Bernstam, Funda; Hunt, Kelly K; Keyomarsi, Khandan.
Afiliação
  • Chen X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. kkeyomar@mdanderson.org XChen11@mdanderson.org.
  • Low KH; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alexander A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karakas C; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hess KR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Carey JPW; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bui TN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vijayaraghavan S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Evans KW; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yi M; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ellis DC; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cheung KL; School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Ellis IO; School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Fu S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hunt KK; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Keyomarsi K; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. kkeyomar@mdanderson.org XChen11@mdanderson.org.
Clin Cancer Res ; 24(24): 6594-6610, 2018 12 15.
Article em En | MEDLINE | ID: mdl-30181387
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Proteínas Nucleares / Expressão Gênica / Proteínas de Ciclo Celular / Resistencia a Medicamentos Antineoplásicos / Ciclina E / Inibidores de Proteínas Quinases / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Proteínas Nucleares / Expressão Gênica / Proteínas de Ciclo Celular / Resistencia a Medicamentos Antineoplásicos / Ciclina E / Inibidores de Proteínas Quinases / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article